Stock Financial Ratios and Split History
MIRN / Mirna Therapeutics, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.
|Market Cap ($M)||34.62|
|Enterprise Value ($M)||19.37|
|Book Value ($M)||60.35|
|Book Value / Share||2.89|
|Price / Book||0.28|
|NCAV / Share||2.95|
|Price / NCAV||0.28|
|Income Statement (mra) ($M)|
|Balance Sheet (mrq) ($M)|
|Cash & Equivalents||79.17|
|Cash / Share||3.80|
|Common Stock Shares Outstanding||20,841,393|
|Common Shares Outstanding||20,856,693|
|Preferred Stock Shares Outstanding||0|
|Altman Z Score||N/A|
|Beneish M Score||N/A|
|Cash Conversion Cycle||N/A|
|Management Effectiveness (mra)|
|Return on Invested Capital (ROIC)||-0.44|
|Return on Assets (ROA)||-0.41|
|Return on Equity (ROE)||-0.44|
|Identifiers and Descriptors|
|Central Index Key (CIK)||1527599|
|SIC 2834 - Pharmaceutical Preparations|
Stock splits are used by Mirna Therapeutics, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.
Peers - Pharmaceutical Preparations (2834)
ENDV / Endonovo Therapeutics, Inc.
AXIM / Axim Biotechnologies, Inc.
PRTT / Protect Pharmaceutical Corp
NNAB / NanoAntibiotics, Inc.
Related News Stories
At Stockmatusow, we look for developmental biotech companies we believe provide a legitimate chance at long-term large alpha potential. These factors include, but are not limited to; (60-2)
Synlogic develops medicines using probiotic engineering to treat inborn errors of metabolism, immunomodulation, and metabolic diseases. (95-2)